Y Kusunoki

1.1k total citations
13 papers, 866 citations indexed

About

Y Kusunoki is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Y Kusunoki has authored 13 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Y Kusunoki's work include Cancer therapeutics and mechanisms (6 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Y Kusunoki is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Y Kusunoki collaborates with scholars based in Japan. Y Kusunoki's co-authors include Nobuhide Takifuji, M. Fukuoka, N Masuda, S. Kudoh, Masayuki Nishioka, Kazuhiko Nakagawa, Mitsutaka Takada, Kunihiko Matsui, M. Fukuoka and Kaoru Kubota and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Y Kusunoki

13 papers receiving 824 citations

Peers

Y Kusunoki

ONCOL

MB

PRM

EPIDE

BE

Takashi Yana Japan

Masayuki Nishioka Japan

Peter D. de Ipolyi United States

Guy Rosner Israel

Seigo Ueda Japan

C. Benckhuysen Netherlands

Roswitha Runge Germany

K Karrer Austria

M. Houman Fekrazad United States

E. Franzese Italy

Takashi Yana Japan

Y Kusunoki

611 ×1.1

ONCOL

411 ×0.9

MB

461 ×1.4

PRM

291 ×1.0

EPIDE

186 ×1.8

BE

Citations per year, relative to Y Kusunoki Y Kusunoki (= 1×) peers Takashi Yana

Countries citing papers authored by Y Kusunoki

Since Specialization

Citations

This map shows the geographic impact of Y Kusunoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Kusunoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Kusunoki more than expected).

Fields of papers citing papers by Y Kusunoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Kusunoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Kusunoki. The network helps show where Y Kusunoki may publish in the future.

Co-authorship network of co-authors of Y Kusunoki

This figure shows the co-authorship network connecting the top 25 collaborators of Y Kusunoki. A scholar is included among the top collaborators of Y Kusunoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Kusunoki. Y Kusunoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Masuda, N, K Matsui, Nobuhide Takifuji, et al.. (1998). Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer.. Journal of Clinical Oncology. 16(10). 3329–3334. 87 indexed citations

2.

Kubota, Kaoru, Kiyoyuki Furuse, Masaaki Kawahara, et al.. (1997). Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 40(6). 469–474. 47 indexed citations

3.

Takada, M, N Masuda, Eiji Matsuura, et al.. (1995). Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay. British Journal of Cancer. 71(1). 160–165. 68 indexed citations

4.

Kusunoki, Y, Shunichi Negoro, Nobuhide Takifuji, et al.. (1995). Relationship between the Pharmacokinetics of Irinotecan and Diarrhea during Combination Chemotherapy with Cisplatin. Japanese Journal of Cancer Research. 86(4). 406–413. 36 indexed citations

5.

Nitta, Takashi, M. Fukuoka, Y Kusunoki, et al.. (1995). Significance of Serum Neuron-specific Enolase as a Predictor of Relapse of Small Cell Lung Cancer. Japanese Journal of Clinical Oncology. 25(5). 179–83. 5 indexed citations

6.

Furuse, Kiyoyuki, M. Fukuoka, H. Kato, et al.. (1993). A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group.. Journal of Clinical Oncology. 11(10). 1852–1857. 201 indexed citations

7.

Masuda, N, M. Fukuoka, Y Kusunoki, et al.. (1992). CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.. Journal of Clinical Oncology. 10(8). 1225–1229. 380 indexed citations

8.

Fukuoka, M., et al.. (1992). Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer: A phase II study. Lung Cancer. 8(3-4). 242–242. 1 indexed citations

9.

Sobue, Tomotaka, et al.. (1991). Sensitivity and Specificity of Lung Cancer Screening in Osaka, Japan. Japanese Journal of Cancer Research. 82(10). 1069–1076. 20 indexed citations

10.

Matsui, Kazuo, M. Fukuoka, Norikazu Masuda, et al.. (1991). [High-dose Tegafur (FT) for primary lung cancer: a phase I trial].. PubMed. 18(4). 593–9. 1 indexed citations

11.

Takifuji, Nobuhide, Shoji Kudoh, Kunihiko Matsui, et al.. (1991). [The significance of CA-50, SLX and ST-439 in lung cancer].. PubMed. 29(7). 802–7. 1 indexed citations

12.

Fukuoka, Masahiro, et al.. (1990). Evaluation of high-dose etoposide combined with cisplatin for treating relapsed small cell lung cancer. Cancer. 65(12). 2635–2640. 15 indexed citations

13.

Takifuji, Nobuhide, M. Fukuoka, Shunichi Negoro, et al.. (1990). [Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].. PubMed. 17(3 Pt 2). 429–34. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact